Single-dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patients.
The pharmacokinetics of thalidomide in nine human immunodeficiency virus-infected patients were studied. Single doses of thalidomide were well absorbed, with mean peak concentrations (+/- standard deviations) of 1.17 +/- 0.21 and 3.47 +/- 1.14 microg/ml in the 100- and 300-mg dosing groups, respecti...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1997
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164214/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9420064/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.12.2797 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|